Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Prademagene zamikeracel (pz-cel) is Abeona’s investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa. The Company’s fully integrated cell and gene therapy cGMP manufacturing facility served as the manufacturing site for pz-cel used in its Phase 3 VIITAL™ trial, and is capable of supporting commercial production of pz-cel upon FDA approval. The Company’s development portfolio also features AAV-based gene therapies for ophthalmic diseases with high unmet medical need. Abeona’s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases.
Company Details
- Employees
- 192
- Founded
- 2015
- Address
- 6555 Carnegie Avenue, Cleveland,oh 44103,united States
- Phone
- (216)287-5408
- tm****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- abeonatherapeutics.com
- Keywords
- Gene Therapy, Biotechnology, Cell Therapy, Rare Disease, Epidermolysis Bullosa, Pediatric Rare Diseases, manufacturing.
- HQ
- Cleveland, OH
Abeona Therapeutics Questions
Abeona Therapeutics's helpline number is (216)287-5408
Abeona Therapeutics's website is abeonatherapeutics.com
Abeona Therapeutics's LinkedIn profile is https://www.linkedin.com/company/abeonatherapeutics
Abeona Therapeutics has
192 employees.
View email and phone details for 192
employees at Abeona Therapeutics.
Abeona Therapeutics's industry is
Biotechnology Research
Abeona Therapeutics's top competitors are
Anavex Life Sciences,
Nuvation Bio,
Biospherix, Llc,
Dianthus Therapeutics, Inc.,
Immunic Therapeutics,
Transcend Therapeutics,
Waypoint Bio,
Soleno Therapeutics, Inc.,
Gilgamesh Pharmaceuticals,
Lexeo Therapeutics.
Abeona Therapeutics's support email address is tmiller@abeonatherapeutics.com
Abeona Therapeutics's categories are Biotechnology Research
Abeona Therapeutics's founding year is 2015
